141 related articles for article (PubMed ID: 8922810)
1. Serum antibody concentrations of cytotoxin, exotoxin, A, lipopolysaccharide, protease, and elastase and survival of patients with Pseudomonas aeruginosa bacteremia.
Baltch AL; Franke M; Smith RP; Asperilla M; Griffin P; Michelsen P; Lutz F
Clin Infect Dis; 1996 Nov; 23(5):1109-16. PubMed ID: 8922810
[TBL] [Abstract][Full Text] [Related]
2. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
[No Abstract] [Full Text] [Related]
3. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
Homma JY; Tanimoto H
Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
[No Abstract] [Full Text] [Related]
4. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients.
Trancassini M; De Vito D; Quattrucci S; Cipriani P
New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606
[TBL] [Abstract][Full Text] [Related]
6. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application.
Homma JY; Tanimoto H
Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353
[No Abstract] [Full Text] [Related]
7. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.
West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM
JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
[TBL] [Abstract][Full Text] [Related]
9. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
[TBL] [Abstract][Full Text] [Related]
10. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)].
Yamamoto M; Kubota Y; Matsuura M; Homma JY
Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639
[No Abstract] [Full Text] [Related]
11. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections.
Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K
Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-linked immunosorbent assay for detection of antibodies to Pseudomonas aeruginosa exoproteins.
Granström M; Wretlind B; Markman B; Pavlovskis OR; Vasil ML
Eur J Clin Microbiol; 1985 Apr; 4(2):197-200. PubMed ID: 3924608
[TBL] [Abstract][Full Text] [Related]
13. Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies.
Rao AR; Splaingard MS; Gershan WM; Havens PL; Thill A; Barbieri JT
Pediatr Pulmonol; 2005 May; 39(5):402-7. PubMed ID: 15666370
[TBL] [Abstract][Full Text] [Related]
14. Reliable enzyme-linked immunosorbent assay systems for pathogenic factors of Pseudomonas aeruginosa alkaline proteinase, elastase, and exotoxin A: a comparison of methods for labeling detection antibodies with horseradish peroxidase.
Shigematsu T; Suda N; Okuda K; Fukushima J
Microbiol Immunol; 2007; 51(12):1149-59. PubMed ID: 18094533
[TBL] [Abstract][Full Text] [Related]
15. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis.
Granström M; Ericsson A; Strandvik B; Wretlind B; Pavlovskis OR; Berka R; Vasil ML
Acta Paediatr Scand; 1984 Nov; 73(6):772-7. PubMed ID: 6441448
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections.
Pollack M; Longfield RN; Karney WW
Am J Med; 1983 Jun; 74(6):980-7. PubMed ID: 6407308
[TBL] [Abstract][Full Text] [Related]
17. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
Jagger KS; Robinson DL; Franz MN; Warren RL
J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
[No Abstract] [Full Text] [Related]
19. Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.
Grzybowski J; Trafny EA; Wrembel-Wargocka J; Patzer J; Dzierzanowska D; Zawistowska-Marciniak I; Kłos M
J Clin Microbiol; 1989 Jun; 27(6):1367-71. PubMed ID: 2502560
[TBL] [Abstract][Full Text] [Related]
20. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
Klinger KW; Shuster CW; Klinger J
Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
